PTK2 and acute lymphoblastic leukemia: Collectively, these results demonstrate that WT161 inhibits PKA activity by reducing intracellular cAMP levels, leading to suppression of the VLA-4/FAK signaling pathway and consequent impairment of ALL cell adhesion and migration capabilities.